Clinical Trial: Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME)

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07491380) titled 'Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME)' on March 18.

Brief Summary: This is a prospective validation study, multicenter, open-label, single-arm study, evaluating the concordance between capillary microsampling (using the VAMS Mitra device) and venous sampling in patients undergoing CDK4/6 therapy.

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: OTHER: Capillary samples using the VAMS Mitra device

Five blood samples will be collected at a single time point during treatment, in accordance with the r...